Normal view MARC view
  • National Academies (U.S.).

National Academies (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II (Corporate Name)

Preferred form: National Academies (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II

Machine generated authority record.

Work cat.: (JGU)2943269: National Academies (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, author., A risk-characterization framework for decision-making at the Food and Drug Administration /

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library